君实生物:2025中期报告

香港交易所
Sep 26

牛牛AI助手已提取核心信息2025年上半年,君实生物收入总额约人民币11.7亿元,较2024年同期增加约49%,其中药品销售收入约人民币10.6亿元,同比增长49%。核心产品拓益®国内销售收入约人民币9.5亿元,较2024年同期增长约42%。报告期内本公司拥有人应占亏损减少至人民币4.1亿元,较2024年同期减少约人民币2.3亿元或约36%。报告期内,公司研发开支总额约人民币7.5亿元,较2024...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10